Equity Details
Price & Market Data
Price: $147.0
Daily Change: +$2.85 / 1.94%
Daily Range: $141.2 - $147.0
Market Cap: $30,979,557,376
Daily Volume: 1,422,593
Performance Metrics
1 Week: -1.01%
1 Month: 6.91%
3 Months: 51.82%
6 Months: 138.9%
1 Year: 248.0%
YTD: 82.95%
About Revolution Medicines, Inc. (RVMD)
Dive deep into Revolution Medicines, Inc. (RVMD)'s market performance. Current price: 147.0, daily change: +$2.85 / 1.94%. Market cap: 30,979,557,376. All key performance metrics are available, from 1-week to 1-year and YTD.
Company Details
Employees: 883
Sector: Health technology
Industry: Pharmaceuticals: other
Country: United States
Details
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.